Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
|Articles|September 25, 1998

The American Journal of Managed Care

  • September 1998 - Special Issue
  • Volume 4
  • Issue 2 SP

Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

Download PDF: Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

Articles in this issue

over 27 years ago

Technology Assessment of Medical Devices

over 27 years ago

Technology Assessment, Coverage Decisions, and Conflict: The Role of Guidelines

over 27 years ago

Technology Assessment of Medical Devices at the Center for Devices and Radiological Health

over 27 years ago

Role of Technology Assessment in Health Benefits Coverage for Medical Devices

over 27 years ago

Transmyocardial Laser Revascularization: A Qualitative Systematic Review

over 27 years ago

Device Evaluation and Coverage Policy in Workers' Compensation: Examples from Washington State

over 27 years ago

The Limited State of Technology Assessment for Medical Devices: Facing the Issues

over 27 years ago

Healthcare Technology Assessment: Methods, Framework, and Role in Policy Making

Related Content